Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New approach by USCF researchers analyzes how well different engineered T tells work against cancer.
Our bodies can keep tumors at bay, even if our cells harbor cancer-driving mutations.
NCI researchers may have found a clever way to give immune cells the upper hand.
A new study in mice suggests that it is an important step for cancer metastasis, and details how that happens.
Allergy meds were linked to longer survival among cancer patients treated with immune checkpoint inhibitors.
The men who did yoga had improvements in functional, physical and social well-being, sexual function and fatigue.
Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.
Obesity may render T cells around tumors less powerful by causing them to alter how they generate and use energy, a new study suggests.
Long-lived memory immune cells continue to provide protection even after antibody levels drop.
Scientists at Dana-Farber Cancer Institute have created molecular ON-OFF switches to regulate the activity of CAR T cells.
Researchers have evidence that cholesterol-lowering drugs might offer a way to improve success rates of immunotherapy.
The nanoparticles led to more cancer-killing immune cells and slowed the growth of melanoma in mice.
Conclusions from four recent studies could open up potential strategies for boosting the effectiveness of cancer immunotherapies.
How researchers are tweaking engineered immune cells’ cancer-targeting receptors—and why it matters.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.